- Home
- ALEC vs SLGB Comparison
ALEC vs SLGB Comparison
Compare ALEC & SLGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- SLGB
- Stock Information
- Founded
- ALEC 2013
- SLGB 2017
- Country
- ALEC United States
- SLGB Hong Kong
- Employees
- ALEC N/A
- SLGB N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- SLGB Integrated Freight & Logistics
- Sector
- ALEC Health Care
- SLGB Industrials
- Exchange
- ALEC Nasdaq
- SLGB Nasdaq
- Market Cap
- ALEC 124.0M
- SLGB 144.3M
- IPO Year
- ALEC 2019
- SLGB 2025
- Fundamental
- Price
- ALEC $1.50
- SLGB $2.99
- Analyst Decision
- ALEC Hold
- SLGB
- Analyst Count
- ALEC 9
- SLGB 0
- Target Price
- ALEC $3.40
- SLGB N/A
- AVG Volume (30 Days)
- ALEC 4.6M
- SLGB 2.1M
- Earning Date
- ALEC 11-06-2025
- SLGB 11-16-2025
- Dividend Yield
- ALEC N/A
- SLGB N/A
- EPS Growth
- ALEC N/A
- SLGB N/A
- EPS
- ALEC N/A
- SLGB 0.03
- Revenue
- ALEC $81,130,000.00
- SLGB $92,917,774.00
- Revenue This Year
- ALEC N/A
- SLGB N/A
- Revenue Next Year
- ALEC $290.64
- SLGB N/A
- P/E Ratio
- ALEC N/A
- SLGB $101.24
- Revenue Growth
- ALEC 46.77
- SLGB N/A
- 52 Week Low
- ALEC $0.87
- SLGB $2.42
- 52 Week High
- ALEC $6.14
- SLGB $6.08
- Technical
- Relative Strength Index (RSI)
- ALEC 27.08
- SLGB N/A
- Support Level
- ALEC $1.45
- SLGB N/A
- Resistance Level
- ALEC $1.60
- SLGB N/A
- Average True Range (ATR)
- ALEC 0.20
- SLGB 0.00
- MACD
- ALEC -0.20
- SLGB 0.00
- Stochastic Oscillator
- ALEC 8.45
- SLGB 0.00
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.